A study led by BHP founder-member the University of Birmingham has revealed for the first time that the contraceptive pill can reduce the risk of type 2 diabetes by over a quarter in women with pol…

Research led by scientists at BHP founder-member the University of Birmingham has identified a new specific population of cells that plays a key role in the affect arthritis has on the body and the…

Combining three existing drugs – a commonly-used anti-epileptic, a contraceptive steroid and a cholesterol-lowering agent – could form an effective and non-toxic treatment for a range of aggressive…

A new project has been launched across BHP members, aiming to address racial and ethical health inequalities using artificial intelligence (AI). STANDING Together, being led by BHP founding member…

BHP founder-member University Hospitals Birmingham is the first site in the UK to treat a uveal melanoma patient with the new therapy Tebentafusp outside a clinical trial. Uveal melanoma is a rare …

Experts from BHP member Birmingham Women’s and Children’s NHS Foundation Trust have transformed the treatment of children’s eye cancer with pioneering new research. Dr Trevor Cole and Dr Amy Ger…